Literature DB >> 16814740

Expression and characterization of a functional canine variant of cytochrome b5 reductase.

Glenn W Roma1, Louis J Crowley, Michael J Barber.   

Abstract

Cytochrome b5 reductase (cb5r), a member of the flavoprotein transhydrogenase family of oxidoreductase enzymes, catalyzes the transfer of reducing equivalents from the physiological electron donor, NADH, to two molecules of cytochrome b5. We have determined the correct nucleotide sequence for the putative full-length, membrane-associated enzyme from Canis familiaris, and have generated a heterologous expression system for production of a histidine-tagged variant of the soluble, catalytic diaphorase domain, comprising residues I33 to F300. Using a simple two-step chromatographic procedure, the recombinant diaphorase domain has been purified to homogeneity and demonstrated to be a simple flavoprotein with a molecular mass of 31,364 (m/z) that retained both NADH:ferricyanide reductase and NADH:cytochrome b5 reductase activities. The recombinant protein contained a full complement of FAD and exhibited absorption and CD spectra comparable to those of a recombinant form of the rat cytochrome b5 reductase diaphorase domain generated using an identical expression system, suggesting similar protein folding. Oxidation-reduction potentiometric titrations yielded a standard midpoint potential (Eo') for the FAD/FADH2 couple of -273+/-5 mV which was identical to the value obtained for the corresponding rat domain. Thermal denaturation studies revealed that the canine domain exhibited stability comparable to that of the rat protein, confirming similar protein conformations. Initial-rate kinetic studies revealed the canine diaphorase domain retained a marked preference for NADH versus NADPH as reducing substrate and exhibited kcat's of 767 and 600 s(-1) for NADH:ferricyanide reductase and NADH:cytochrome b5 reductase activities, respectively, with Km's of 7, 8, and 12 microM for NADH, K3Fe(CN)6, and cytochrome b5, respectively. Spectral-binding constants (Ks) determined for a variety of NAD+ analogs indicated the highest and lowest affinities were observed for APAD+ (Ks=71 microM) and PCA+ (Ks=>31 mM), respectively, and indicated the binding contributions of the various portions of the pyridine nucleotide. These results provide the first correct sequence for the full-length, membrane-associated form of C. familiaris cb5r and provide a direct comparison of the enzymes from two phylogenetic sources using identical expression systems that indicate that both enzymes have comparable spectroscopic, kinetic, thermodynamic, and structural properties.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16814740     DOI: 10.1016/j.abb.2006.04.021

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  7 in total

1.  Study of the individual cytochrome b5 and cytochrome b5 reductase domains of Ncb5or reveals a unique heme pocket and a possible role of the CS domain.

Authors:  Bin Deng; Sudharsan Parthasarathy; WenFang Wang; Brian R Gibney; Kevin P Battaile; Scott Lovell; David R Benson; Hao Zhu
Journal:  J Biol Chem       Date:  2010-07-14       Impact factor: 5.157

2.  Evaluation of polymorphisms in the sulfonamide detoxification genes CYB5A and CYB5R3 in dogs with sulfonamide hypersensitivity.

Authors:  J Funk-Keenan; J Sacco; Y Y Amos Wong; S Rasmussen; A Motsinger-Reif; L A Trepanier
Journal:  J Vet Intern Med       Date:  2012-07-21       Impact factor: 3.333

3.  NADH-dependent cytochrome b5 reductase and NADPH methemoglobin reductase activity in the erythrocytes of Oncorhynchus mykiss.

Authors:  M C Saleh; S McConkey
Journal:  Fish Physiol Biochem       Date:  2012-06-26       Impact factor: 2.794

4.  The Zebrafish Cytochrome b5/Cytochrome b5 Reductase/NADH System Efficiently Reduces Cytoglobins 1 and 2: Conserved Activity of Cytochrome b5/Cytochrome b5 Reductases during Vertebrate Evolution.

Authors:  Matthew B Amdahl; Elin E Petersen; Kaitlin Bocian; Stefan J Kaliszuk; Anthony W DeMartino; Sagarika Tiwari; Courtney E Sparacino-Watkins; Paola Corti; Jason J Rose; Mark T Gladwin; Angela Fago; Jesús Tejero
Journal:  Biochemistry       Date:  2019-07-10       Impact factor: 3.162

5.  Familial Congenital Methemoglobinemia in Pomeranian Dogs Caused by a Missense Variant in the NADH-Cytochrome B5 Reductase Gene.

Authors:  H Shino; Y Otsuka-Yamasaki; T Sato; K Ooi; O Inanami; R Sato; M Yamasaki
Journal:  J Vet Intern Med       Date:  2018-01-22       Impact factor: 3.333

6.  Genetic cause for congenital methemoglobinemia in an Australian Pomeranian dog.

Authors:  Shijia Zhou; Rick Tearle; Raziallah Jafari Jozani; Bethany Winra; Olaf Schaaf; Anthony Nicholson; Anne Peaston
Journal:  J Vet Intern Med       Date:  2019-02-14       Impact factor: 3.333

7.  Characterization of a novel nicotinamide adenine dinucleotide-cytochrome b5 reductase mutation associated with canine hereditary methemoglobinemia.

Authors:  Yayoi Otsuka-Yamasaki; Osamu Inanami; Haruka Shino; Reeko Sato; Masahiro Yamasaki
Journal:  J Vet Med Sci       Date:  2020-12-21       Impact factor: 1.267

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.